2-64636540-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014755.3(SERTAD2):c.332C>T(p.Ala111Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000163 in 1,598,506 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014755.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SERTAD2 | NM_014755.3 | c.332C>T | p.Ala111Val | missense_variant | 2/2 | ENST00000313349.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SERTAD2 | ENST00000313349.3 | c.332C>T | p.Ala111Val | missense_variant | 2/2 | 1 | NM_014755.3 | P1 | |
SERTAD2 | ENST00000476805.2 | n.1061C>T | non_coding_transcript_exon_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000791 AC: 12AN: 151692Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000125 AC: 3AN: 240490Hom.: 0 AF XY: 0.00000771 AC XY: 1AN XY: 129724
GnomAD4 exome AF: 0.00000968 AC: 14AN: 1446814Hom.: 0 Cov.: 32 AF XY: 0.00000697 AC XY: 5AN XY: 717860
GnomAD4 genome AF: 0.0000791 AC: 12AN: 151692Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74094
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2023 | The c.332C>T (p.A111V) alteration is located in exon 2 (coding exon 1) of the SERTAD2 gene. This alteration results from a C to T substitution at nucleotide position 332, causing the alanine (A) at amino acid position 111 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at